R&D Systems Recombinant Human PILR-beta Fc Chimera Protein CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9828PR050
DescriptionThe Recombinant Human PILR-beta Fc Chimera Protein is derived from HEK293. The Recombinant Human PILR-beta Fc Chimera Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2μm filtered solution in PBS with Trehalose.|
|45.7 kDa (monomer)|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|<0.10 EU per 1μg of the protein by the LAL method.|
|activating receptor PILRbeta, Activating receptor PILR-beta, Cell surface receptor FDFACT, cell surface receptor FDFACT1, cell surface receptor FDFACT2, FDFACT, FDFACT1, FDFACT2, paired immunoglobin-like receptor beta, paired immunoglobin-like type 2 receptor beta, paired immunoglobulin-like receptor beta, paired immunoglobulin-like type 2 receptor beta, PILRB, PILRbeta|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|Reconstitute at 500μg/mL in PBS.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok